-
Spurs must banish 'loser' mentality despite injury woes, says De Zerbi
-
Arsenal must manage emotions of title race says Arteta
-
Nepal temple celebrates return of stolen Buddha statue
-
US Fed official says rate hikes may be needed if inflation surges
-
Fixture pile-up no excuse for Man City in title race: Guardiola
-
Iran offers new proposal amid stalled US peace talks
-
Gulf countries' plans to bypass Hormuz still far off, experts warn
-
Luis Enrique says 'unique' PSG-Bayern first leg could have gone either way
-
Rebels take key military camp in Mali's north
-
Turkish police fire tear gas, arrest hundreds at Istanbul May Day rallies
-
Lufthansa apologises for lost Oscar after US airport security row
-
French hub monitors Hormuz tensions from afar
-
Flick happy Raphinha back for Barca with title in sight
-
UN troubled by rejected appeal of Cambodian opposition leader
-
Activists on Gaza aid flotilla detained by Israel disembark in Crete
-
Oil steady after wild swing, stocks diverge in thin trading
-
Lufthansa says searching for Oscar lost after US airport security row
-
Howe says Saudi backers are fully behind Newcastle
-
Chinese swimmer Sun Yang reports cyberbullying to police
-
Solomon Islands leader to face no-confidence vote after appeal court loss
-
Salah 'deserves big send-off', says Liverpool boss Slot
-
UK police charge man with stabbing attack on two Jewish Londoners
-
Solomon Islands leader loses court appeal, must face no confidence vote
-
Former world skating champion Uno joins pro eSports team
-
Japan baseball umpire hit by bat still unconscious two weeks on
-
Nakatani says won't be intimidated in sold-out Inoue title clash
-
T-Wolves eliminate Nuggets as Knicks demolish Hawks in NBA playoffs
-
Timberwolves eliminate Jokic's Nuggets from NBA playoffs
-
Arsenal seek to ramp up heat on Man City in title race
-
PSG closing in on another French title before Bayern second leg
-
Espanyol must stop rot against Real Madrid as Barca eye title
-
Leipzig can book return to Champions League as Bundesliga top-four rivals meet
-
Injuries add to Bath's challenge for Champions Cup semi in Bordeaux
-
Karius getting 'back to the top' with promotion-chasing Schalke
-
King Charles arrives in Bermuda after whirlwind US visit
-
Clashes erupt in Australian town over death of Indigenous girl
-
Iran war redraws sea routes with Africa as the pivot
-
India's cows offer biogas alternative to Mideast energy crunch
-
Afghans celebrate spring in bright red poppy fields
-
Finland's 'Flamethrower' and 4 other Eurovision favourites
-
Crude edges up after wild swing, stocks track Wall St rally
-
Eurovision: 70 years of geopolitics, patriotism, music and glitter
-
Knicks demolish Hawks to advance in NBA playoffs
-
Blockbuster EU-Mercosur trade deal enters into force
-
'Uncharted': US court ruling shakes up battle for Congress
-
Florida executes man who spent nearly 50 years on death row
-
Ace lifts rookie Green to share of LPGA lead as Korda lurks
-
Wear a bulletproof vest? I don't want to look fat, says Trump
-
Formerra Appoints Matt Borowiec as Chief Commercial Officer
-
World No. 4 Young leads at PGA Cadillac Championship
Coalition of states vows to protect access to abortion pill under Trump review
A coalition of attorneys general across states including New York, Minnesota and Arizona vowed Monday to protect access to mifepristone, the medication used in the majority of abortions in the United States.
The move comes as the Trump administration has reportedly launched a review into the medication's safety, in what many abortion rights' organizations have dubbed a blatant attempt to undermine health care access.
"The decision to reexamine access to this medication was made in response to a scientifically baseless letter and ignores decades of research that prove mifepristone is safe and effective," read the joint statement that included New York's Attorney General Letitia James, who co-led the coalition of 20 officials in the effort.
"Medical decisions should be left between patients, their families, and their providers – and they should be guided by science, not political agendas," the statement continued.
"If access to mifepristone is challenged, we will take action to protect it," it added.
Officials who co-signed the initiative represented Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Jersey, New Mexico, Oregon, Rhode Island, Vermont, Washington state, and the District of Columbia.
Trump's health chief Robert F. Kennedy Jr and FDA Commissioner Marty Makary reportedly delivered a letter to 22 Republican attorneys general saying that the FDA was conducting its own review of the pill.
Proponents of reviewing mifepristone's safety have cited a study -- which was not peer-reviewed and published on a website, not in a scientific journal -- conducted by a conservative think-tank.
The Ethics & Public Policy Center (EPPC) says its priorities include "pushing back against the extreme progressive agenda while building a consensus for conservatives."
The medication has been used for 25 years in the United States. It is the most common method for abortion care and also routinely used for managing early miscarriage.
Mifepristone, which prevents pregnancy progression, and misoprostol, which empties the uterus, are approved to terminate a pregnancy up to 70 days of gestation in the United States.
N.Schaad--VB